Myeloproliferative Leukemia Mutation Screening MPL S505N W515L
Introduction
The Myeloproliferative Leukemia Mutation Screening MPL S505N W515L is a vital diagnostic test designed to detect specific genetic mutations linked to myeloproliferative neoplasms (MPNs), a group of disorders characterized by the overproduction of blood cells. This test plays a crucial role in the accurate diagnosis, prognosis, and treatment planning for patients suspected of having these conditions.
What the Test Measures
This test focuses on identifying mutations in the MPL gene, specifically the S505N and W515L variants. These mutations can influence the behavior of blood cells and are associated with various forms of leukemia, particularly myeloproliferative disorders. By detecting these mutations, healthcare providers can tailor treatment strategies to improve patient outcomes.
Who Should Consider This Test
Individuals who should consider the Myeloproliferative Leukemia Mutation Screening include:
- Patients showing symptoms of blood disorders, such as fatigue, unexplained weight loss, or excessive bleeding.
- Individuals with a family history of myeloproliferative neoplasms.
- Patients with abnormal blood test results suggesting potential leukemia or related conditions.
Benefits of Taking the Test
The benefits of the Myeloproliferative Leukemia Mutation Screening MPL S505N W515L include:
- Accurate diagnosis of myeloproliferative disorders, allowing for timely intervention.
- Personalized treatment strategies based on genetic findings, improving overall care.
- Informed decision-making for patients and their healthcare providers.
Understanding Your Results
Results from the Myeloproliferative Leukemia Mutation Screening will indicate the presence or absence of the S505N and W515L mutations. A positive result may suggest a higher risk for developing myeloproliferative disorders, while a negative result can help rule out these conditions. It is essential to discuss your results with a healthcare provider to understand their implications fully.
Test Pricing
| Price Type | Amount (NGN) |
|---|---|
| Discount Price | 135000 NGN |
| Regular Price | 180000 NGN |
Booking the Test
The Myeloproliferative Leukemia Mutation Screening (MPL – S505N; W515L) can be performed with a Doctor’s prescription. Please note that a prescription is not applicable for surgery and pregnancy cases or individuals planning to travel abroad. To book your test, contact us today at +2348077798758 or visit our website to schedule an appointment.
Turnaround time for results is approximately 5-7 days, and samples are collected from Bone Marrow or Peripheral Blood using an EDTA Vacutainer (2ml).
